Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-26 Sale |
2023-09-26 4:30 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
33,805 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-15 Sale |
2023-08-17 4:35 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
1,205 | $168.8 | $203,409 | 33,805 (Direct) |
View |
| 2023-07-28 Sale |
2023-08-01 4:29 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
40,000 | $164.54 | $6,581,428 | 75,010 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:21 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
1,311 | $83.77 | $109,829 | 30,885 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 4:44 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
9,317 | $86.77 | $808,436 | 32,196 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 5:17 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
96,996 | $87.67 | $8,503,621 | 173,143 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-06 4:28 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
2,166 | $88.25 | $191,148 | 48,509 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 5:30 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $162.5 | $9,750,300 | 150,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-15 Option Award |
2024-08-16 6:18 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Bir Dawn Carter Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2024-05-09 Option Award |
2024-05-10 4:05 pm |
N/A 2034-05-08 |
GERON CORP | GERN | Bir Dawn Carter Director |
180,000 | $0 | 180,000 (Direct) |
View |
| 2023-07-28 Exercise |
2023-08-01 4:29 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
40,000 | $22.57 | 75,010 (Direct) |
View |
| 2023-07-28 Conversion |
2023-08-01 4:29 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
40,000 | $0 | 75,010 (Direct) |
View |
| 2023-07-28 Exercise |
2023-08-01 4:29 pm |
N/A 2026-12-07 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
40,000 | $0 | 75,010 (Direct) |
View |
| 2023-07-06 Option Award |
2023-07-10 4:42 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
4,125 | $0 | 35,010 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:53 pm |
N/A 2033-05-30 |
GERON CORP | GERN | Bir Dawn Carter Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 5:17 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $21.05 | 173,143 (Direct) |
View |
| 2023-03-06 Conversion |
2023-03-08 5:17 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $0 | 173,143 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 5:17 pm |
N/A 2026-09-06 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
90,000 | $0 | 173,143 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:11 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
79,325 | $0 | 114,325 (Direct) |
View |
| 2022-05-10 Option Award |
2022-05-11 6:14 pm |
N/A 2032-05-09 |
GERON CORP | GERN | Bir Dawn Carter Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:09 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 9:23 pm |
N/A 2031-05-10 |
GERON CORP | GERN | Bir Dawn Carter Director |
83,000 | $0 | 83,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:10 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:30 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $21.05 | 150,000 (Direct) |
View |
| 2020-11-09 Conversion |
2020-11-10 5:30 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $0 | 150,000 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:30 pm |
N/A 2026-09-06 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $0 | 150,000 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-09 6:11 pm |
N/A 2030-06-04 |
GERON CORP | GERN | Bir Dawn Carter Director |
83,000 | $0 | 83,000 (Direct) |
View |